🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871741
Treatments Being Tested
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-13
Trial ID
NCT00970307
Treatments Being Tested
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
This is a multicenter extension study of two European randomized, double-bl...
Status
Completed
Location
Multiple Locations
Start Date
2016-04-26
Trial ID
NCT02759354
Treatments Being Tested
The purpose of the study is to determine whether prophylactic antipyretic t...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00294294
Treatments Being Tested
Primary Objective: To describe the persistence of Hep B antibodies (Ab) at...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02610348
The aim of the study is to assess the persistence of anti-Hep B antibody at...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02697474
Treatments Being Tested